Business

Around the Region

Cubist drug gets expanded OK

Advertisement

Cubist Pharmaceuticals Inc. said that the Food and Drug Administration has approved expanded use for Entereg, a drug used after gastrointestinal surgery.

Entereg is designed to accelerate healing following certain surgeries, Lexington-based Cubist said. Entereg was approved in the United States in 2008.

“Delayed GI (gastrointestinal) recovery is one of the most common causes of prolonged hospital stays in patients undergoing major abdominopelvic surgery,” Cubist chief scientific officer Steven Gilman said in a statement. “We are pleased that doctors will have the option to help speed GI recovery for appropriate patients who have undergone surgeries that included a bowel resection.”

Chris Reidy can be reached at reidy@globe.com.
Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com